Trends in blindness due to diabetic retinopathy among adults aged 18–69 years over a decade in Ireland

Diabetes Research and Clinical Practice

Volumn 121, Issue , 2016, Pages 1-8

  Tracey, M L ^a   McHugh, S M ^a   Fitzgerald, A P ^a   Buckley, C M ^a,b   Canavan, R J ^c   Kearney, P M ^a  

^a UNIVERSITY COLLEGE CORK   (Ireland)

^b HEALTH SERVICE EXECUTIVE   (Ireland)

^c ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

Author keywords

Adults; Diabetes; Diabetic retinopathy; Epidemiology; Trends

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; ATTRIBUTABLE RISK; BLINDNESS; DIABETIC RETINOPATHY; FEMALE; HEALTH PROGRAM; HUMAN; INCIDENCE; IRELAND; MAJOR CLINICAL STUDY; MALE; MICROANGIOPATHY; POPULATION DISTRIBUTION; POPULATION RISK; PREVALENCE; PREVENTIVE MEDICINE; RISK ASSESSMENT; RISK FACTOR; SCREENING; SENSITIVITY ANALYSIS; TREND STUDY; VISUAL IMPAIRMENT; ADOLESCENT; AGED; COMPLICATION; MIDDLE AGED; REGISTER; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BLINDNESS; DIABETIC RETINOPATHY; FEMALE; HUMANS; INCIDENCE; IRELAND; MALE; MIDDLE AGED; PREVALENCE; REGISTRIES; YOUNG ADULT;

EID: 84985931284     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2016.08.016     Document Type: Article

References (47)

1. [1] Stevens, G.A., White, R.A., Flaxman, S.R., Price, H., Jonas, J.B., Keeffe, J., et al. Global prevalence of vision impairment and blindness: magnitude and temporal trends, 1990–2010. Ophthalmology 120:12 (2013), 2377–2384.
2. [2] Kelliher, C., Kenny, D., O'Brien, C., Trends in blind registration in the adult population of the Republic of Ireland 1996–2003. Br J Ophthalmol 90:3 (2006), 367–371.
3. [3] Green, D., Ducorroy, G., McElnea, E., Naughton, A., Skelly, A., O'Neill, C., et al. The cost of blindness in the Republic of Ireland 2010–2020. J Ophthalmol, 2016, 2016, 4691276.
4. [4] World Health Organization. Action plan for the prevention of avoidable blindness and visual impairment; 2009–2013.
5. [5] van Dieren, S., Beulens, J.W., van der Schouw, Y.T., Grobbee, D.E., Neal, B., The global burden of diabetes and its complications: an emerging pandemic. Eur J Cardiovasc Prev Rehabil 17:Suppl 1 (2010), S3–S8.
6. [6] Genz, J., Scheer, M., Trautner, C., Zöllner, I., Giani, G., Icks, A., Reduced incidence of blindness in relation to diabetes mellitus in southern Germany?. Diabet Med 27:10 (2010), 1138–1143.
7. [7] Tracey, M.L., Gilmartin, M., O'Neill, K., Fitzgerald, A.P., McHugh, S.M., Buckley, C.M., et al. Epidemiology of diabetes and complications among adults in the Republic of Ireland 1998–2015: a systematic review and meta-analysis. BMC Public Health 16:1 (2016), 1–13.
8. [8] International Diabetes Federation, IDF diabetes atlas. 6th ed., 2013 Brussels, Belgium.
9. [9] Yau, J.W.Y., Rogers, S.L., Kawasaki, R., Lamoureux, E.L., Kowalski, J.W., Bek, T., et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care, 2012.
10. [10] Liew, G., Michaelides, M., Bunce, C., A comparison of the causes of blindness certifications in England and Wales in working age adults (16–64 years), 1999–2000 with 2009–2010. BMJ Open, 4(2), 2014, e004015.
11. [11] Ciulla, T.A., Amador, A.G., Zinman, B., Diabetic retinopathy and diabetic macular edema: pathophysiology, screening, and novel therapies. Diabetes Care 26:9 (2003), 2653–2664.
12. [12] Fong, D.S., Aiello, L.P., Ferris, F.L., Klein, R., Diabetic retinopathy. Diabetes Care 27:10 (2004), 2540–2553.
13. [13] Williams, R., Van Gaal, L., Lucioni, C., Assessing the impact of complications on the costs of Type II diabetes. Diabetologia 45:7 (2002), S7–S13.
14. [14] Lee, C.M., Colagiuri, R., Magliano, D.J., Cameron, A.J., Shaw, J., Zimmet, P., et al. The cost of diabetes in adults in Australia. Diabetes Res Clin Pract 99:3 (2013), 385–390.
15. [15] Association, A.D., Economic costs of diabetes in the U.S. in 2012. Diabetes Care 36:4 (2013), 1033–1046.
16. [16] European Forum Against Blindness. The cost of preventable blindness 2014 [cited 2015 10 September]. Available from: http://www.efabeu.org/media/1043/cob-infographic_pan-eu-results_14-october.pdf.
17. [17] Lloyd, A., Nafees, B., Gavriel, S., Rousculp, M.D., Boye, K.S., Ahmad, A., Health utility values associated with diabetic retinopathy. Diabet Med 25:5 (2008), 618–624.
18. [18] Arun, C.S., Ngugi, N., Lovelock, L., Taylor, R., Effectiveness of screening in preventing blindness due to diabetic retinopathy. Diabet Med 20:3 (2003), 186–190.
19. [19] Arun, C.S., Al-Bermani, A., Stannard, K., Taylor, R., Long-term impact of retinal screening on significant diabetes-related visual impairment in the working age population. Diabet Med 26:5 (2009), 489–492.
20. [20] Hall, H.N., Chinn, D.J., Sinclair, A., Styles, C.J., Epidemiology of blindness attributable to diabetes in Scotland: change over 20 years in a defined population. Diabet Med 30:11 (2013), 1349–1354.
21. [21] Forster, A.S., Forbes, A., Dodhia, H., Connor, C., Du Chemin, A., Sivaprasad, S., et al. Changes in detection of retinopathy in type 2 diabetes in the first 4 years of a population-based diabetic eye screening program: retrospective cohort study. Diabetes Care 36:9 (2013), 2663–2669.
22. [22] Bäcklund, L.B., Algvere, P.V., Rosenqvist, U., New blindness in diabetes reduced by more than one-third in Stockholm County. Diabet Med 14:9 (1997), 732–740.
23. [23] Arora, S., Kolb, S., Goyder, E., McKibbin, M., Trends in the incidence of visual impairment certification secondary to diabetic retinopathy in the Leeds metropolitan area, 2005–2010. Diabet Med 29:7 (2012), e6–e112.
24. [24] Mc Hugh, S., O'Keeffe, J., Fitzpatrick, A., de Siun, A., O'Mullane, M., Perry, I., et al. Diabetes care in Ireland: a survey of general practitioners. Prim Care Diabetes 3:4 (2009), 225–231.
25. [25] Diabetic RetinaScreen. The National Diabetic Retinal Screen Programme 2015 [cited 2015 30 April]. Available from: http://www.hse.ie/eng/about/Who/clinical/natclinprog/diabetesprogramme/.
26. [26] Health Service Executive. National Clinical Programme for Diabetes 2010 [cited 2014 29 Aug]. Available from: http://www.hse.ie/eng/about/Who/clinical/natclinprog/diabetesprogramme/.
27. [27] Baxter, S.L., Wormald, R.P., Musa, J.M., Patel, D., Blindness registers as epidemiological tools for public health planning: a case study in Belize. Epidemiol Res Int, 2014, 2014, 8.
28. [28] Munier, A., Gunning, T., Kenny, D., O'Keefe, M., Causes of blindness in the adult population of the Republic of Ireland. Br J Ophthalmol 82:6 (1998), 630–633.
29. [29] National Council for the Blind of Ireland. NCBI Working for people with sight loss 2010 [cited 2015 3 Jan]. Available from: https://www.ncbi.ie/about-ncbi.
30. [30] Health Service Executive. Blind Welfare Allowance 2013 [cited 2015 07 June]. Available from: http://www.hse.ie/eng/services/list/1/schemes/bwa/.
31. [31] Deloitte Access Economics, The economic impact of vision impairment and blindness in the Republic of Ireland. 2011, NCBI Dublin.
32. [32] Central Statistics Office. Census of Population Interactive Tables 2014 [cited 2015 2 March]. Available from: http://www.cso.ie/px/pxeirestat/Database/eirestat/Annual%20Population%20Estimates/Annual%20Population%20Estimates_statbank.asp?SP=Annual%20Population%20Estimates&Planguage=0.
33. [33] Ruta, L.M., Magliano, D.J., Lemesurier, R., Taylor, H.R., Zimmet, P.Z., Shaw, J.E., Prevalence of diabetic retinopathy in Type 2 diabetes in developing and developed countries. Diabet Med 30:4 (2013), 387–398.
34. [34] Buckley, C.M., O'Farrell, A., Canavan, R.J., Lynch, A.D., De La Harpe, D.V., Bradley, C.P., et al. Trends in the incidence of lower extremity amputations in people with and without diabetes over a five-year period in the Republic of Ireland. PLoS ONE, 7(7), 2012, e41492.
35. [35] Belkin, M., Kalter-Leibovici, O., Chetrit, A., Skaat, A., Time trends in the incidence and causes of blindness in Israel. Am J Ophthalmol, 155(2), 2013, 404.
36. [36] Klein, R., Lee, K.E., Knudtson, M.D., Gangnon, R.E., Klein, B.E.K., Changes in visual impairment prevalence by period of diagnosis of diabetes: the Wisconsin epidemiologic study of diabetic retinopathy. Ophthalmology 116:10 (2009), 1937–1942.
37. [37] Wong, T.Y., Mwamburi, M., Klein, R., Larsen, M., Flynn, H., Hernandez-Medina, M., et al. Rates of progression in diabetic retinopathy during different time periods: a systematic review and meta-analysis. Diabetes Care 32:12 (2009), 2307–2313.
38. [38] Gregg, E.W., Li, Y., Wang, J., Rios Burrows, N., Ali, M.K., Rolka, D., et al. Changes in diabetes-related complications in the United States, 1990–2010. N Engl J Med 370:16 (2014), 1514–1523.
39. [39] Klein, R., Lee, K.E., Gangnon, R.E., Klein, B.E.K., The 25-year incidence of visual impairment in Type 1 diabetes mellitus: the Wisconsin epidemiologic study of diabetic retinopathy. Ophthalmology 117:1 (2010), 63–70.
40. [40] Vallance, J.H., Wilson, P.J., Leese, G.P., McAlpine, R., MacEwen, C.J., Ellis, J.D., Diabetic retinopathy: more patients, less laser: a longitudinal population-based study in Tayside, Scotland. Diabetes Care 31:6 (2008), 1126–1131.
41. [41] Bunce, C., Evans, J., Fraser, S., Wormald, R., BD8 certification of visually impaired people. Br J Ophthalmol 82:1 (1998), 72–76.
42. [42] Barry, R.J., Murray, P.I., Unregistered visual impairment: is registration a failing system?. Br J Ophthalmol 89:8 (2005), 995–998.
43. [43] Kumar, N., Goyder, E., McKibbin, M., The incidence of visual impairment due to diabetic retinopathy in Leeds. Eye 20:4 (2005), 455–459.
44. [44] Leese, G.P., Boyle, P., Feng, Z., Emslie-Smith, A., Ellis, J.D., Screening uptake in a well-established diabetic retinopathy screening program: the role of geographical access and deprivation. Diabetes Care 31:11 (2008), 2131–2135.
45. [45] Millett, C., Dodhia, H., Diabetes retinopathy screening: audit of equity in participation and selected outcomes in South East London. J Med Screen 13:3 (2006), 152–155.
46. [46] Gulliford, M.C., Dodhia, H., Chamley, M., McCormick, K., Mohamed, M., Naithani, S., et al. Socio-economic and ethnic inequalities in diabetes retinal screening. Diabet Med 27:3 (2010), 282–288.
47. [47] Scanlon, P., Diabetic retinopathy screening: progress or lack of progress. Visual dysfunction in diabetes. 2012, Springer, 17–29.